Justin Lande
Internal Medicine · Danville, KYNPI 1538542378
Payments from drug & device makers
Across 815 payments — averaging $73.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$48K
- Eli Lilly$2K
- Novo Nordisk$2K
- AbbVie$1K
- GSK$1K
- Pfizer$561
- plus $5K from 46 others
What the payments were for
- Consulting fees$1,9503%
- Speaking & faculty fees$45,30076%
- Travel & lodging$1,6033%
- Food & beverage$10,71918%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,577 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 517 | $674,086 |
| MounjaroTirzepatide | 262 | $358,176 |
| JardianceEmpagliflozin | 275 | $330,886 |
| TrulicityDulaglutide | 155 | $257,293 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 157 | $167,642 |
| Repatha SureclickEvolocumab | 149 | $143,816 |
| EliquisApixaban | 148 | $143,613 |
| Tresiba Flextouch U-100Insulin Degludec | 81 | $68,054 |
| VraylarCariprazine Hcl | 48 | $65,557 |
| LinzessLinaclotide | 53 | $52,741 |
| XareltoRivaroxaban | 45 | $48,995 |
| JanuviaSitagliptin Phosphate | 40 | $45,499 |
| FarxigaDapagliflozin Propanediol | 40 | $45,182 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $32,220 |
| ProliaDenosumab | 15 | $25,568 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,510 | $674,086517 claims |
| Lilly USA, LLCMounjaro, Trulicity | $48,274 | $615,468417 claims |
| Boehringer IngelheimJardiance | $316 | $330,886275 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,060 | $184,398196 claims |
| PfizerEliquis | $561 | $143,613148 claims |
| AbbVieVraylar, Linzess, Qulipta | $1,193 | $139,851122 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Airsupra | $548 | $101,489121 claims |
| MerckJanuvia, Janumet, Dulera | $377 | $64,13770 claims |
| Johnson & JohnsonXarelto | $148 | $48,99545 claims |
| AmgenProlia | $552 | $25,56815 claims |
| NovartisEntresto | $469 | $21,04920 claims |
| Astellas Pharma US IncMyrbetriq | $157 | $20,88737 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Danville
- Tory TormaDanville$15K
- Mark AdamsLondon$15.4M
- Matthew WenkerErlanger$12.8M
- Jason ChesneyLouisville$6.3M
- Neil FarrisLexington$3M
- David JohnsonOwensboro$787K
- Hollis ClarkMurray$780K
- Fares KhaterWhitesburg$412K
- Christopher PhillipsPaducah$315K
- Cynthia Bowman-StroudPaducah$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.